Works matching IS 03125963 AND DT 2018 AND VI 57 AND IP 1


Results: 10
    1
    2
    3
    4

    Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.

    Published in:
    2018
    By:
    • Kansagra, Kevinkumar;
    • Parmar, Deven;
    • Jani, Rajendra;
    • Srinivas, Nuggehally;
    • Lickliter, Jason;
    • Patel, Harilal;
    • Parikh, Devang;
    • Heading, Heather;
    • Patel, Hardik;
    • Gupta, Rahul;
    • Shah, Chintan;
    • Patel, Maulik;
    • Dholakia, Vyom;
    • Sukhadiya, Raghav;
    • Jain, Mukul;
    • Parmar, Krupi;
    • Barot, Kinjal;
    • Kansagra, Kevinkumar A;
    • Jani, Rajendra H;
    • Srinivas, Nuggehally R
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10